Recent Advances in Self-Exciting Photodynamic Therapy. 2020

Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
Marshall Laboratory of Biomedical Engineering, Laboratory of Evolutionary Theranostics (LET), International Cancer Center, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, China.

Photodynamic therapy (PDT) is already (Food and Drug Administration) FDA approved and used in the clinic for oncological treatment of pancreatic, lung, esophagus, bile duct, and of course several cancers of skin. It is an important tool in the oncological array of treatments, but for it exist several shortcomings, the most prominent of which is the shallow depth penetration of light within tissues. One-way researchers have attempted to circumvent this is through the creation of self-exciting "auto-PDT" nanoplatforms, which do not require the presence of an external light source to drive the PDT process. Instead, these platforms are driven either through oxidative chemical excitation in the form of chemiluminescence or radiological excitation from beta-emitting isotopes in the form of Cherenkov luminescence. In both, electronic excitations are generated and then transferred to the photosensitizer (PS) via Resonance Energy Transfer (RET) or Cherenkov Radiation Energy Transfer (CRET). Self-driven PDT has many components, so in this review, using contemporary examples from literature, we will breakdown the important concepts, strategies, and rationale behind the design of these self-propagating PDT nanoplatforms and critically review the aspects which make them successful and different from conventional PDT. Particular focus is given to the mechanisms of excitation and the different methods of transfer of excited electronic energy to the photosensitizer as well as the resulting therapeutic effect. The papers reviewed herein will be critiqued for their apparent therapeutic efficiency, and a basic rationale will be developed for what qualities are necessary to constitute an "effective" auto-PDT platform. This review will take a biomaterial engineering approach to the review of the auto-PDT platforms and the intended audience includes researchers in the field looking for a new perspective on PDT nanoplatforms as well as other material scientists and engineers looking to understand the mechanisms and relations between different parts of the complex "auto-PDT" system.

UI MeSH Term Description Entries

Related Publications

Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
April 2008, Anti-cancer agents in medicinal chemistry,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
May 2021, Chemistry, an Asian journal,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
November 2021, Pharmaceutics,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
May 2018, Quantitative imaging in medicine and surgery,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
May 2024, Photobiomodulation, photomedicine, and laser surgery,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
January 2022, Frontiers in chemistry,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
December 2021, Advanced healthcare materials,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
January 2017, Combinatorial chemistry & high throughput screening,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
May 2022, Chemical science,
Nicholas Thomas Blum, and Yifan Zhang, and Junle Qu, and Jing Lin, and Peng Huang
August 2023, Pharmaceutics,
Copied contents to your clipboard!